drugset / Trial / NCT07018635
A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
Non-randomizedSequentialOpen-labelTreatment
Summary
This study is conducted to assess the effect of itraconazole, rifampin, and acid-reducing agents on INCB161734 pharmacokinetics when administered orally in healthy participants.
Timeline
- Start
- 2025-07-16
- Primary completion
- 2025-09-29
- Completion
- 2025-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | — | Oral |
| Subject | Famotidine | Other / unclassified | — | Oral |
| Subject | INCB161734 | Unknown | — | Oral |
| Subject | Itraconazole | Small molecule | — | Oral |
| Subject | Rifampicin | Small molecule | — | Oral |
Indications
No indication recorded.